Pricing Log in Create free account

Apollomics Inc. (APLM) vs Clene Inc. (CLNN)

Apollomics Inc. and Clene Inc. are both Biotechnology companies. Clene Inc. is the larger, with a market value of $63.1M against $53.2M — 1.2× the size. Apollomics Inc. has the higher net margin (0.00% vs −11,271.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Apollomics Inc. leads on 8 and Clene Inc. on 3.

Valuation

Metric APLM CLNN Biotechnology median
P/E n/m n/m 10.85
P/S — 239.62 9.49
P/B n/m n/m 2.18
Price to free cash flow n/m n/m 25.85
EV/EBITDA n/m n/m 0.70
EV/Sales n/m 224.37 8.99
Earnings yield (0.33%) (53.92%) (31.76%)
Free cash flow yield 0.00% (29.15%) (21.84%)

Profitability

Metric APLM CLNN Biotechnology median
Gross margin — 68.49% 68.51%
Operating margin — (8,928.57%) 0.00%
Net margin 0.00% (11,271.43%) 0.00%
Free cash flow margin 0.00% (6,984.45%) 0.00%
Return on equity 0.00% 197.50% (50.82%)
Return on assets 0.00% (120.65%) (46.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APLM CLNN Biotechnology median
Revenue growth (TTM) — 11.21% 6.96%
EPS growth (last fiscal year) 85.66% 53.26% 29.88%
Revenue growth, 5-year CAGR 32.77% (0.59%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APLM CLNN Biotechnology median
Debt to equity 0.00 (0.42) 0.00
Current ratio 0.96 0.85 4.84
Net debt to EBITDA 0.37 (0.39) 1.01

Dividend

Metric APLM CLNN Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric APLM CLNN Biotechnology median
Market cap 53.19m 63.07m 163.56m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack